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Abstract
Rationale—Cardiac fibrosis contributes to pathogenesis of atrial fibrillation (AF), which is the
most sustained arrhythmia and a major cause of morbidity and mortality. Although it has been
suggested that Ca2+ signals are involved in fibrosis promotion, the molecular basis of Ca2+
signaling mechanisms and how Ca2+ signals contribute to fibrogenesis remain unknown.
Objective—To determine the molecular mechanisms of Ca2+-permeable channel(s) in human
atrial fibroblasts, and to investigate how Ca2+ signals contribute to fibrogenesis in human AF.
Methods and Results—We demonstrate that the transient receptor potential melastatin related
7 (TRPM7) is the molecular basis of the major Ca2+-permeable channel in human atrial
fibroblasts. Endogenous TRPM7 currents in atrial fibroblasts resemble the biophysical and
pharmacological properties of heterologous expressed TRPM7. Knocking down TRPM7 by small
hairpin RNA (shRNA) largely eliminates TRPM7 current and Ca2+ influx in atrial fibroblasts.
More importantly, atrial fibroblasts from AF patients show a striking upregulation of both TRPM7
currents and Ca2+ influx and are more prone to myofibroblast differentiation, presumably due to
the enhanced expression of TRPM7. TRPM7-shRNA markedly reduced basal AF fibroblast
differentiation. Transforming growth factor β1 (TGF-β1), the major stimulator of atrial fibrosis,
requires TRPM7-mediated Ca2+ signal for its effect on fibroblast proliferation and differentiation.
Furthermore, TGF-β1 induced differentiation of cultured human atrial fibroblasts is well
correlated with an increase of TRPM7 expression induced by TGF-β1.
Conclusions—Our results establish that TRPM7 is the major Ca2+-permeable channel in human
atrial fibroblasts, and likely plays an essential role in TGF-β1-elicited fibrogenesis in human AF.
Keywords
Atrial Fibrillation; TRPM7; Ca2+ signaling; TGF-β1; fibrogenesis
INTRODUCTION
Cardiac fibrosis is a detrimental factor that results in abnormalities in cardiac conduction,
stiffening of the ventricular walls, and loss of contractility, thereby contributing to a variety
of heart diseases, including hypertrophy, heart failure, and arrhythmia 1. Atrial fibrillation
(AF) is the most sustained clinical arrhythmia and is a major cause of morbidity and
mortality 2. Recent studies have demonstrated that structural remodeling as a result of
fibrosis is one of the fundamental mechanisms underlying the perpetuation of AF, and
contributes synergistically with electrical and contractile remodeling to AF substrate 2-6.
Atrial fibrosis is a hallmark feature of arrhythmogenic structural remodeling in clinical AF 7.
Increased amount of fibrosis occurs in not only AF patients associated with other cardiac
diseases 8, 9, but also in those with lone AF 8, 10. There is a positive correlation between the
amounts of fibrosis and the persistence of AF 9, suggesting that atrial fibrosis results in
structural remodeling to promote AF. The causal importance of fibrosis in occurrence and
persistence of AF is strongly supported by studies in animal models in which selective atrial
fibrosis caused by overexpression of TGF-β1 increases AF vulnerability 11, 12. Thus,
understanding the mechanism of fibrogenesis is important in developing new therapeutic
strategies aimed at preventing or reversing structural remodeling in AF.
Fibrosis represents excessive deposition of extracellular matrix proteins (ECM) synthesized
by cardiac fibroblasts or myofibroblasts upon stimulation 13, 14. Myofibroblasts are not
found in normal cardiac tissue 15. In response to pathological stimuli, such as myocardial
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injury, oxidative stress, mechanical stretch, autocrine-paracrine mediators, and inflammatory
stimuli, fibroblasts proliferate, migrate and undergo phenotypic changes and differentiate
into myofibroblasts 14, 16. Myofibroblasts might also be derived from endothelial cells in
fibrotic heart 17. By producing growth factors, cytokines, chemokines, ECM proteins, and
proteases 18, 19, myofibroblasts play a pivotal role in fibrosis. Inhibition of myofibroblast
differentiation may prove to be a common and effective approach to attenuate cardiac
fibrosis, regardless of the initial stimuli. However, little is known about the molecular
mechanisms underlying fibroblast differentiation.
Ca2+ signals are essential for diverse cellular functions including differentiation, gene
expression, cell proliferation, growth and death 20. In cardiac fibroblasts, several lines of
evidence suggest that Ca2+ entry is essential for fibroblast functions. Chelating external
Ca2+ by EGTA prevents substance P induced proliferation of cultured rat cardiac fibroblasts
21, 22. Eliminating external Ca2+ to prevent Ca2+ influx attenuates H2O2 induced IL-6
mRNA expression 23. In mechanical-stimulation or stretch-induced membrane potential
studies, both Ca2+-entry and Ca2+-release are involved in generation of MIP (MIP:
mechanically induced potential) 24, 25. A stretch induced current can be blocked by
Gadlinium (Gd3+) 26, a non-selective cation channel blocker. Recently, it has been shown
that intracellular Ca2+ contributes to Angiotensin II (Ang II) induced proliferation of cardiac
fibroblasts 27. In an in vivo study, Mibefradil, a Ca2+ channel blocker, significantly reduced
collagen production and fibroblast differentiation in rats treated with AngII or Aldosterone
28. These studies indicate that Ca2+ entry through Ca2+-permeable ion channels is essential
for gene expression and fibrosis promotion. Therefore, understanding the molecular basis of
Ca2+-permeable channels is crucial for elucidating the molecular mechanisms of
proliferation and differentiation of cardiac fibroblasts.
Fibroblasts have been reported to have depolarized resting membrane potentials. Measured
by standard microelectrode techniques in multicellular tissues, the resting membrane
potential of atrial fibroblasts is between -31 to -16 mV 29-31. There is no evidence indicating
that functional voltage-gated calcium channels exist in the fibroblast 32. The transient
receptor potential (TRP) channels are responsible for Ca2+ entry in various non-excitable
and excitable cells 33-35. TRP channels are non-voltage gated but are activated by a variety
of different stimuli including receptor activation, oxidative stress, mechanical stretch, cell
metabolites, and thermal or sensory stimuli 33-35. TRP channels also enable individual cells
to sense changes in their local environment. Given that cardiac fibroblasts encounter a
variety of pathological conditions, it seems that TRP channels could be the potential
candidates for Ca2+ signaling in cardiac fibroblasts.
In order to understand Ca2+ signaling mechanisms in cardiac fibroblasts and potential roles
of Ca2+ signals in the cardiac fibrogenesis cascade, we investigated the molecular basis of
Ca2+-permeable channels in human atrial fibroblasts isolated from AF patients and normal
sinus rhythm patients (NSR), and studied how Ca2+ influx contributes to TGF-β1 induced
fibrogenesis process. We discovered that TRPM7, a Ca2+-permeable cation channel which
also possesses protein kinase function 36-38, underlies the Ca2+ signaling mechanism in
human atrial fibroblasts. TRPM7 has been reported to play a vital role in embryonic
development 39 and anoxic cell death 40. We found that TRPM7 is the major Ca2+-
permeable channel in human atrial fibroblasts. Knocking down TRPM7 by shRNA largely
eliminates the endogenous TRPM7 currents as well as Ca2+ influx in atrial fibroblasts.
Strikingly, TRPM7 and TRPM7-medaited Ca2+ influx are drastically up-regulated in
fibroblasts from AF patients. In addition, inhibition of TRPM7-mediated Ca2+ influx renders
fibroblasts less sensitive to TGF-β1 induced proliferation and differentiation, indicating that
TRPM7-mediated Ca2+ signal is necessary for TGF-β1 elicited fibrogenesis. On parallel
with myofibroblast differentiation, TRPM7 is up-regulated by TGF-β1 in cultured
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fibroblasts. Taken together, our results indicate that TRPM7-mediated Ca2+ signal
contributes to fibroblast differentiation and may mediate the fibrogenic effect of TGF-β1.
This study suggests that inhibition of TRPM7 may prove to be an effective approach to
reduce fibroblast differentiation and therefore attenuate fibrosis during human AF.
METHODS
Human Cardiac Tissue Sample Collection and fibroblasts isolation
Myocardial samples of the right atria were collected during cardiac surgery. All procedures
involving human tissue use were approved by the institutional review boards of the
University of Connecticut Health Center. Atrial fibroblasts were isolated by collagenase (see
details in the supplementary methods). Freshly isolated fibroblasts from AF and NSR
patients were used for patch-clamp experiment to compare the TRPM7 current amplitude.
Molecular Biology
RT-PCR was performed as we previously reported 41 by using the primers shown in Online
Table II. TRPM7-specific shRNAs were designed and constructed into lenti-viral delivery
system. The efficiency of the shRNAs was tested in the TRPM7 over-expression HEK-293
cells. The one with higher efficiency was used in the experiments (see the Online Data
Supplement)
Electrophysiology
Whole-cell and single-channel currents were recorded as we reported previously 42, 43.
Internal Mg2+-free solution was used for whole-cell current recording and inside-out
configuration was applied for single channel current recording. For details, see the Online
Data Supplement.
Ratio Ca2+ imaging experiments
Ca2+ influx was measured using ratio Ca2+ imaging system and analyzed using NIS-
Elements (Nikon). The F340/F380 ratio in the presence of 20 mM Ca2+ was normalized to
that of 1 μM Ionomycin (Iono) elicited Ca2+ signal (see details in supplementary methods).
Ca2+ influx was also measured with/without store depletion by 2 μM thapsigargin (Tg) in
some experiments as specified in text.
Immunostaining
Fibroblasts were fixed by 4% formaldehyde and immmunostained with α-SMA antibody.
The immunostained cells were analyzed using a Zeiss LSM 510 confocal microscope.
Details are described in the Online Data Supplement.
Western Blot
The protein expression levels of TRPM7 and α-SMA were evaluated by Western blot
experiments. GAPDH was used as a loading control (the Online Data Supplement).
Data Analysis
Pooled data are presented as mean ± SEM. Dose–response curves were fitted by an equation
of the form E=Emax{1/[1+(EC50/C)n]}, where E is the effect at concentration C, Emax is
maximal effect, EC50 is the concentration for half-maximal effect and n is the Hill
coefficient. Statistical comparisons were made using two-way ANALYSIS of variance
(ANOVA) and two-tailed t-test with Bonferroni correction. Fisher’s exact test was used for
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analysis of percentage differences for patients’ database. P < 0.05 indicated statistical
significance.
RESULTS
TRPM7 is the major Ca2+-permeable channel in human atrial fibroblasts
To understand which Ca2+ permeable channel is responsible for Ca2+ entry in cardiac
fibroblasts, we first investigated the expression of Ca2+-permeable TRP channels. Among
the 27 human TRP channel genes 33, we found that TRPM7 is abundantly expressed in
human atrial fibroblasts (Online Figure I). To study whether TRPM7 constitutes functional
channels in the fibroblasts, we applied voltage-clamp to investigate the current
characteristics. As shown in Figure 1, a TRPM7-like current was readily elicited by a
voltage ramp protocol ranging from -120 to +100 mV. The current-voltage relation (I-V
relation) with small inward current and strong outward rectification (Figure 1A) is similar to
the typical characteristics of the recombinant TRPM7 36, 37. Heterologous expressed
TRPM7 exhibits several unique features, including single channel conductance, potentiation
by low external pH, inhibition by low concentrations of 2-aminoethoxydiphenyl borate (2-
APB) but potentiation by high concentration of 2-APB 43, 44. We then tested if the
endogenous TRPM7-like current in cardiac fibroblasts has similar properties. The single
channel conductance of TRPM7-like current (Figure 1B) is similar to that of TRPM7 over-
expressed in CHO cells 43. TRPM7-like current was significantly potentiated by low
extracellular pH (Figure 1C) with an EC50 of 3.9 pH unit (Online Figure IIB). Like TRPM7,
TRPM7-like current was inhibited by low concentrations of 2-APB with an IC50 of 32.1 μM
(Figure 1E-F). High concentrations of 2-APB enhanced TRPM7-like current (Figure 1E),
but the concentration-dependence of the effect was not assessed because of poor solubility
of 2-APB at high concentrations. All of these features of the endogenous TRPM7-like
currents in human atrial fibroblasts are indistinguishable from those of exogenously
expressed TRPM7 42, 43, suggesting that the TRPM7-like current in the human cardiac
fibroblasts is encoded by TRPM7.
To further confirm that TRPM7 constitutes TRPM7-like currents, we applied TRPM7-
specific shRNA to the fibroblasts (Figure 2). The efficiency of TRPM7-shRNA was first
examined in HEK-293 cells over-expressing human TRPM7 (Figure 2A-B). The current
amplitude of TRPM7 was decreased by ~70% after TRPM7-shRNA treatment. Similarly,
after treatment for 5 days, the current amplitude of TRPM7-like currents in human
fibroblasts was significantly reduced by TRPM7-shRNA in comparison with the cells
treated with Scr-shRNA (Figure 2C-D), indicating that TRPM7 is indeed the molecule
encoding TRPM7-like currents in human atrial fibroblasts. Based on these findings, we refer
to the TRPM7-like currents as “TRPM7” in the following text.
TRPM7 is responsible for Ca2+entry in human atrial fibroblasts
We next asked whether TRPM7 is responsible for Ca2+ entry in atrial fibroblasts. Using
ratio Ca2+ imaging measurements, we found that Ca2+ influx was decreased by 62% after
fibroblasts were treated with TRPM7-shRNA for 5 days, indicating that TRPM7 is the major
Ca2+-permeable channel in human atrial fibroblasts (Figure 2E-F). To elucidate whether
there are other Ca2+-permeable channels which may contribute to Ca2+ influx in human
atrial fibroblasts, we used the conditions specific for TRPV2 45, TRPV4 46 or TRPC6 47, 48
current recording, and tested if functional currents of these channels are present in human
atrial fibroblasts. As shown in Figure 3, TRPV2-like currents could not be elicited by 200
μM 2-APB in human atrial fibroblasts (Figure 3A), whereas 2-APB readily activated
TRPV2 overexpressed in HEK293 cells (Figure 3B-C). The conditions used for activating
TRPV4 expressed in HEK293 cells (Figure 3E-F) failed to induce any TRPV4-like current
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in atrial fibroblasts. TRPC6 can be elicited by activation of Gq-like receptor activation
(Figure 3H-I). However, neither using LPA to activate EDG7 receptor (Figure 3G) nor
including GTPγS in the pipette solution (Online Figure III) was effective in inducing
TRPC6-like current in atrial fibroblasts. These results, summarized in Figure 3, indicate that
TRPV2, TRPV4, and TRPC6 do not constitute functional currents even though their
expression was detectable by RT-PCR (Online Figure I). Therefore, it is unlikely that
TRPV2, TRPV4 or TRPC6 contribute to Ca2+ entry in human atrial fibroblasts.
It appears that TRPC1 is abundantly expressed at mRNA level (Online Figure I) in human
atrial fibroblasts. Since TRPC1 may form heteromeric channels with TRPC4 or TRPC5 49,
we attempted to record heteromeric currents with I-V relations similar to those of TRPC1/
TRPC4 (or TRPC1/TRPC5). However, including GTPγs in the pipette solution failed to
induce any TRPC1/TRPC4- or TRPC1/TRPC5-like current (data not shown), suggesting
that TRPC1 may not be able to form functional heteromeric channels in atrial fibroblasts.
Knocking down hTRPC1 by TRPC1 siRNA did not influence Ca2+ influx or fibroblast
differentiation (Online Figure IV), further indicating that TRPC1 may not be able to
contribute Ca2+ influx in human atrial fibroblasts.
We next investigated whether store depletion-activated Ca2+ channel (ICRAC) may influence
Ca2+ entry in atrial fibroblasts. As shown in Figure 5, store-depletion by 5 μM thapsigargin
(Tg) did not induce any current, suggesting that store depletion activated channels are not
functionally expressed in human atrial fibroblasts. Moreover, Ca2+ influx was not changed
by Tg, further suggesting that store-depletion does not contribute to Ca2+ signals in human
atrial fibroblasts. We also investigated whether TRPV2, TRPV4, TRPC1/TRPC4, TRPC6
and ICRAC currents are present in fibroblasts from AF patients, and found that TRPM7
current is the only current that we were able to record in fibroblasts from both NSR and AF
patients. Therefore, it appears that endogenous TRPM7 is the major channel which mediates
Ca2+ entry in human atrial fibroblasts.
TRPM7 is markedly up-regulated in atrial fibroblasts from AF patients
It has been shown that fibrosis associated structural remodeling is a major contributor to AF
7. However, the Ca2+ signaling mechanism in fibrogenesis is unknown. Our findings that
TRPM7 is the major Ca2+-permeable channel in human atrial fibroblasts provided us an
excellent opportunity to explore how Ca2+ signals are involved in fibrosis associated AF.
The left atrial size of AF patients was similar to that in NSR patients among those enrolled
in the current study (Online Table I), although a larger group of AF and NSR patients,
including those who were not enrolled in the fibroblast study, showed a larger left atrial size
in the AF vs. NSR patients (data not shown). We used freshly isolated fibroblasts from
biopsy specimens for current recording. This eliminated cell culture related factors which
could interfere with the experimental results. We found that TRPM7 currents recorded from
freshly isolated fibroblasts in AF patients were 3- to 5-fold larger than those from NSR
patients (Figure 4). Both inward and outward currents were increased significantly. Since
measurement of outward current amplitude gives a more accurate assessment, we used
outward current amplitude measured at +100 mV for comparison (Figure 4C-D). The
average TRPM7 current density was 32.5 ± 2.3 pA/pF in fibroblasts from AF patients (88
cells from 7 patients) and 11.1±0.5 pA/pF in fibroblasts from NSR patients (87 cells from 8
patients), respectively. The increase in TRPM7 current density appears to be resulted from
increased membrane expression of TRPM7 channel proteins, as the single channel
conductance and open probability of TRPM7 were indistinguishable between the NSR
fibroblasts and AF fibroblasts (Online Figure VI). We were not able to do western blot
experiments to determine TRPM7 protein levels in NSR and AF fibroblasts due to the
limited amount of tissues and limited number of fibroblasts. However, we observed that
whereas we were able to obtained single channel recordings from more than 95% of patches
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in the AF fibroblasts, less than 50% of patches from NSR fibroblasts displayed single
channel openings, suggesting that membrane protein level of TRPM7 was higher in AF
fibroblasts than that in NSR fibroblasts.
To study if the increased TRPM7 currents result in enhanced Ca2+ influx, we used ratio
Ca2+ imaging method to compare the Ca2+ entry through TRPM7 in fibroblasts isolated
from AF and NSR patients. Since TRPM7 channels conduct small inward currents and are
constitutively active, we used 20 mM Ca2+ in order to obtain better signal/noise ratio. In
addition, cells were briefly exposed to a nominally divalent free solution (DVF) in order to
eliminate any blockade of TRPM7 by external Mg2+. As shown in Figure 5, the peak Ca2+
influx in fibroblasts from AF patients was 10-fold greater than Ca2+ influx in the fibroblasts
from NSR patients. This result not only further indicates that TRPM7 is the major Ca2+-
permeable channel responsible for Ca2+ influx in human atrial fibroblasts, but also strongly
implies that TRPM7-mediated Ca2+ signals may play an important role in AF-associated
fibrogenesis.
TRPM7 is required for differentiation of human atrial fibroblasts
As the myofibroflast is the major cell type that synthesizes growth factors, cytokines,
chemokines, and extracellular matrix (ECM) proteins, and plays a pivotal role in
fibrogenesis 13, 19, we tested whether there was a higher percentage of myofibroblasts in the
cells isolated from atrial samples from AF patients than those from NSR patients. As shown
in Figure 6, after 24 hrs culture, without TGF-β1 treatment, cells from AF patients displayed
44% myofibroblasts, whereas only 16% cells from NSR patients were myofibroblats. Such
data suggest that fibroblasts from AF patients are more prone to differentiation into
myofibroblasts. The increased vulnerability to differentiation in the fibroblasts from AF
patients might result from an up-regulated TRPM7 level. After TGF-β1 (10 ng/ml)
induction, 90% of fibroblasts differentiated into myofibroblasts in both NSR and AF groups.
To determine the contribution of TRPM7 to basal differentiation of fibroblasts from AF
patients, AF fibroblasts were treated with TRPM7-shRNA or Scr-shRNA in 1% FBS media
after atrial fibroblasts attached to the coverslips (by culturing for 12 hrs in 10% FBS media)
for 72 hrs. Fibroblasts were then cultured in 10% FBS media for 24 hr, followed by Ca2+
influx and differentiation assessment. As shown in Figure 6C-D, TRPM7-shRNA
significantly decreased Ca2+ influx and inhibited basal AF fibroblast differentiation,
indicating that TRPM7-mediated Ca2+ entry contributes to basal differentiation of AF
fibroblasts.
We further investigated whether TRPM7 is involved in TGF-β1 induced differentiation.
Human atrial fibroblasts from NSR patients were treated with TRPM7-shRNA and scramble
shRNA (Scr-shRNA). TGF-β1 was then applied to induce differentiation after cells were
serum starved for 24 hours. As shown in Figure 7, without TGF-β1 (10 ng/ml) treatment,
there were 30.0% myofibroblasts in the Scr-shRNA treated group and 25.4% myofibroblasts
in the TRPM7-shRNA treated group. This higher basal differentiation of NSR fibroblasts in
comparison with that in Fig. 6 was due to that the fibroblasts were culture in 10% FBS
media for more than 84 hrs, and there is a time-dependent increase in basal differentiation
rate when fibroblasts were cultured in 10% FBS media (Online Figure VII). After TGF-β1
stimulation, the differentiated myofibroblasts in the Scr-shRNA treated group increased to
61.0%, whereas, knocking down of TRPM7 by TRPM7-shRNA significantly reduced the
differentiated myofibroblasts to 34.4%, a level similar to the control group (Figure 7B). The
loss of sensitivity to TGF-β1 in TRPM7-shRNA treated fibroblasts suggests that TRPM7
plays a role in TGF-β1 induce atrial fibroblast differentiation.
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To understand how TRPM7 may be involved in fibroblast differentiation, we quantified
changes of α-SMA protein in scramble- and TRPM7-shRNA treated cells by Western blot.
This experiment was performed by using mouse fibroblasts due to the limited number of
human fibroblasts. To rule out other factors such as residual TGFβ 50 in serum which may
influence differentiation, we applied the TGF-β1 receptor blocker SB431542 as a control for
TGF-β1 treatment. As shown in Figure 7C, the increased protein expression of α-SMA
induced by TGF-β1 was significantly reduced by TRPM7 shRNA, which is consistent with
the immunostaining result in human fibroblasts (Figure 7A-B).
Role of TRPM7 in TGF-β1 induced fibroblast proliferation
We next investigated the role of TRPM7 in proliferation of fibroblasts. Human cardiac
fibroblasts treated with scramble or TRPM7-shRNA were exposed to TGF-β1 (10 ng/ml).
As shown in Figure 7D, TRPM7-shRNA significantly decreased the number of fibroblasts,
suggesting that TRPM7 is also involved in cardiac fibroblast proliferation caused by TGF-
β1.
Regulation of TRPM7 by TGF-β1
As TGF-β1 is the most potent fibrogenesis stimulator, we studied whether expression of
TRPM7 is modulated by TGF-β1. In this experiment, fibroblasts were treated with TGF-β1
or the TGF-β1 receptor blocker SB431542. TRPM7 currents were recorded after the human
atrial fibroblasts were treated for 24 hr. As shown in Figure 8A-B, TRPM7 current density
was increased by about 80% by TGF-β1. Ca2+-influx in TGF-β1 treated fibroblasts was
significantly larger than that of control group (Online Figure VIII). Consistent with the
increased current amplitude, TRPM7 expression at mRNA level assessed by qPCR using
mouse cardiac fibroblasts was increased by 2.8 fold. Although other Ca2+-permeable
channel genes were also up-regulated by TGF-β1 (Online Figure IX), TRPM7 is the only
functional channel which can be measured by current recording in human atrial fibroblasts
(Figure 2-3) and in mouse fibroblasts before and after after TGF-β1 treatment (data not
shown). Moreover, knocking down the abundantly expressed TRPC1 did not alter Ca2+
influx or differentiation of human atrial fibroblasts (Online Figure IV). Therefore, it is likely
that TRPM7 plays a major role in mediating Ca2+ in atrial fibroblasts under normal
conditions and upon TGF-β stimulation. To further understand the correlation between the
changes of TRPM7 induced by TGFβ1 and fibroblast differentiation, we tested TRPM7
protein and α-SMA expression levels by using mouse cardiac fibroblasts. Figure 8C-D
shows that TGF-β1 increased TRPM7 and α-SMA protein expression by 3.8- and 2.1-fold,
respectively. The mRNA level of collagen (type I) as well as collagen production measured
in human atrial fibroblasts was markedly increased by TGF-β1 (Fig. 8E-F). These results
further suggest that up-regulation of TRPM7 underlies the Ca2+ signaling mechanism for
TGF-β1 induced fibroblast differentiation and collagen production, and that TRPM7 may
play a role in TGF-β1 induced atrial fibrogenesis.
DISCUSSION
To our knowledge, this is the first study to report a pathophysiological function of the Ca2+-
permeable cation channel TRPM7 in human disease. We made several new findings in this
study. First, our results reveal that TRPM7 underlies the molecular mechanism of Ca2+
signaling in human atrial fibroblasts. Second, we demonstrate that TRPM7 mediated Ca2+
plays an essential role in atrial fibroblasts proliferation and differentiation. Third, we show
that TRPM7 is markedly up-regulated in AF patients, and that up-regulation of TRPM7
confers increased fibroblast differentiation in AF patients. Our results suggest that TRPM7
mediated Ca2+ may play a pivotal role in fibrogenesis in human AF.
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TRPM7 underlies the molecular mechanism of Ca2+ signaling in human atrial fibroblasts
Ca2+ signals are essential for various cellular functions. Although the importance of fibrosis
in various cardiac diseases has been well appreciated, the Ca2+ signaling mechanisms in
cardiac fibrogenesis are not known. Here we demonstrate that TRPM7 is abundantly
expressed in human atrial fibroblasts, and is the major Ca2+-permeable channel which is
responsible for Ca2+ influx in human atrial fibroblasts.
TRPM7 is a Ca2+-permeable cation channel 36, 37. It is constitutively active and brings Ca2+
into cells under physiological conditions. High intracellular Mg2+ concentration blocks
TRPM7. However, TRPM7 channels show ~50% of their maximum activity at physiological
Mg2+ levels (0.5–1 mM) 36, 51. Extracellular low pH potentiates TRPM7 inward current 42,
and oxidative stress activates TRPM7 40. Membrane stretch 52 and shear stress 38 have been
reported to activate TRPM7. All of these characteristics of TRPM7 suggest that TRPM7
plays a role under pathological conditions, such as ischemia or oxidative stress, which may
initiate the cardiac fibrogenesis cascade.
Our results indicate that TRPM7 is encoded by TRPM7 and that TRPM7 is the major
functional Ca2+-permeable channel in human atrial fibroblasts. Although TRPV2, TRPV4,
TRPC1 and TRPC6 were detectable by RT-PCR, current recording results indicate that there
were no functional TRPV2, TRPV4 or TRPC6 channels in the fibroblasts, making them
unlikely to contribute to Ca2+ signaling in the fibroblasts. TRPV4 is sensitive to stretch 53,
and can be specifically activated by 4α-PDD. We found that in both freshly isolated and
cultured fibroblasts, 4α-PDD was unable to activate TRPV4-like currents (Figure 3). TRPC6
is activated by Gq-linked receptor stimulation, DAG or OAG, or by direct application of
GTPγS in the pipette solution. We could not activate TRPC6-like current by LPA, which
activates the EDG7 receptor 54, or by including GTPγS in the pipette solution (Online
Figure III). These results indicate that TRPC6 is not functionally expressed in human atrial
fibroblasts. A previous study reported that TRPC6 was activated by C-type natriuretic
peptide through PLC activation or directly by OAG in rat cardiac fibroblasts 48. We do not
know the reason for this discrepancy, but human and rat cardiac fibroblasts may express
TRPC6 differently.
Store-depletion activated Ca2+ current (ICRAC) contributes to Ca2+ influx and plays an
important role in cellular functions in a variety of cells 55, 56. In human atrial fibroblasts, we
could not detect ICRAC currents, and did not find that store-depletion could induce Ca2+
influx (Online Figure V) in human atrial fibroblasts. ICRAC, TRPV2, TRPV4, TRPC1 and
TRPC6 currents were not present in AF fibroblasts. Even though we found that TGF-β1 up-
regulates mRNA expression of TRPM7, TRPV2, TRPC1, TRPC3, TRPC4 and TRPC6
(Online Figure IX), TRPM7 current is the only functional current recorded in the fibroblasts
treated with TGF-β1, suggesting that TRPM7 is the major channel mediating Ca2+ entry in
atrial fibroblasts. When TRPM7 was knocked down, Ca2+ influx was substantially
decreased in TRPM7-shRNA treated atrial fibroblasts in comparison with Scr-shRNA
treated atrial fibroblasts, indicating that TRPM7 is needed for Ca2+ entry in fibroblasts.
Taken together, our results indicate that TRPM7 is the major Ca2+-permeable channel which
is responsible for Ca2+ influx in human atrial fibroblasts.
Up-regulation of TRPM7 may underlie TGF-β1 induced fibroblast differentiation in AF
patients
We found that TRPM7 is markedly up-regulated in the fibroblasts from AF patients. Both
current density and Ca2+ influx mediated by TRPM7 from AF patients were significantly
larger than those from NSR patients (Figure 4). Due to the limited amount of tissue and
numbers of human atrial fibroblasts, we could not compare the TRPM7 expression in AF
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and NSR patients by measuring protein levels using Western Blot. Since the only
differences between AF patients and NSR patients is the presence of atrial fibrillation versus
normal sinus rhythm (Online Table I), it appears that atrial fibrillation is the only variable
that correlates with the up-regulated TRPM7. To understand the causal importance of
TRPM7 in AF, we investigated whether TRPM7 influences fibroblast differentiation. We
found that fibroblasts isolated from AF patients are more prone to differentiation under
culture conditions even without TGF-β1 treatment. This inherent tendency to differentiation
could be due to the increased expression level of TRPM7 when the fibroblasts were exposed
to the residual amount of TGFβ in the culture media containing serum 50. Indeed, knocking-
down TRPM7 by TRPM7-shRNA not only markedly reduced basal differentiation of AF
fibroblasts (Fig. 6C-D), but also substantially decreased the number of differentiated
myofibroblasts and the expression level of α-SMA induced by TGF-β1, indicating that
TRPM7 is necessary for fibroblast differentiation. As the myofibroblasts are the primary
cells that synthesize ECM and cytokines, which in turn stimulate the fibrogenesis cascade,
the requirement of TRPM7 for myofibroblast differentiation indicates that TRPM7 mediated
Ca2+ signals play a pivotal role in fibrosis formation.
Fibrogenesis can be triggered by various stimuli, including mechanical stretch, oxidative
stress, hormones, myocardial injury, and autocrine-paracrine mediators 14, 16, among which
TGF-β1 is the most potent stimulator in both in vivo and in vitro conditions. Interestingly,
we found that TRPM7 expression was significantly increased by TGF-β1 in cultured
fibroblasts (Figure 8). The increased TRPM7 expression level induced by TGF-β1 parallels
the fibroblast differentiation as assessed by α-SMA expression and collagen production
(Figure 8C-F). These results indicate that TRPM7 is indispensable for TGF-β1 induced
differentiation, and that the up-regulated TRPM7 may synergize with TGFβ1 in inducing
fibroblast differentiation. It is possible that the up-regulation of TRPM7 by TGF-β1 in
cultured fibroblasts represents the major mechanism by which TRPM7 is up-regulated in AF
patients in vivo. Taken together, our results suggest the following model: In human atria,
TGF-β1 is activated by mechanical stretch, oxidative stress, or other stimuli. TGF-β1 up-
regulates TRPM7, which in turn brings more Ca2+ for TGF-β1 to induce differentiation. The
differentiated myofibroblasts synthesize ECM and cytokines, and excessive accumulation of
ECM forms fibrosis. Cytokines can in turn stimulate TGF-β1 and cause up-regulation of
TRPM7, leading to perpetuation of the fibrogenesis process.
Potential mechanism by which Ca2+signals are involved in TGF-β1 induced fibrosis
Atrial fibrosis plays an important role in the pathology of AF. Although three interrelated
pathways including the renin-angiotensin system, TGF-β1 and the oxidative stress pathways
have been shown to be involved in fibrosis 57-63, many fundamental aspects of fibrogenesis
are still to be established 6, 57. Our results indicate that TRPM7-mediated Ca2+ signal is
another fundamental factor contributing to atrial fibrogenesis cascade.
How does the Ca2+ signal contribute to fibrosis formation? There are several possibilities.
First, Ca2+-dependent but TGF-β1-independent pathways may control fibrotic gene
expression 64-67. Second, Ca2+ signals may influence TGF-β1 via the Smad-independent
pathway 68-70. Third, TGF-β1 can induce Ca2+ entry 71, 72 or integrate with reactive oxygen
species (ROS) associated Ca2+ influx and therefore influence ECM protein synthesis 73
through a ROS activated calcineurin pathway. As TRPM7 can be activated by ROS 40, it is
possible that the ROS activated calcineurin pathway may have contributed to the up-
regulation of TRPM7 by TGF-β1 in human atrial fibroblasts. Fourth, TRPM7-mediated
Ca2+ signals may activate the calcineurin pathway and produce synergistic effect with TGF-
β1 (Smad-dependent pathway) in regulating gene expression. Further studies are required to
understand how TRPM7 mediated Ca2+ signals contribute to TGF-β1 induced fibrogenesis.
Nevertheless, our findings that TRPM7 is the molecular basis for the major Ca2+ entry
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channel in cardiac fibroblasts provide a necessary tool to unravel the mechanisms by which
Ca2+ signals contribute to fibrogenesis.
Potential significance
Atrial fibrosis can be triggered by various factors 13 via different pathways 57. Blocking one
pathway may not be able to attenuate or eliminate fibrosis given the complex pathological
conditions. The TRPM7-mediated Ca2+ signals which are necessary for TGF-β1 induced
fibrogenesis may serve as a common pathway in the fibrogenesis cascade. If so, inhibition of
Ca2+ entry through TRPM7 may attenuate cardiac fibrosis regardless of the original stimuli.
TRPM7 has been shown to be essential for cell viability 74, 75 and is responsible for Ca2+
overload induced cell death under anoxia conditions 40. Although previous studies suggested
that TRPM7 is involved in Mg2+ homeostasis 74, 76, knocking out of the TRPM7 gene
disrupts embryonic development but does not alter Mg2+ homeostasis 39, indicating that
Ca2+ permeation may confer major channel functions of TRPM7. The contribution of the
TRPM7-mediated Ca2+ signal in human atrial fibrogenesis shown in this study is the first
demonstration of an important role of this unique channel in human diseases.
Conclusions
In this study, we establish that the Ca2+-permeable cation channel TRPM7 underlies Ca2+
signaling mechanisms in the cardiac fibrogenesis, making TRPM7 the first known Ca2+-
permeable channel involved in the genesis of cardiac fibrosis. More importantly, our results
demonstrate that TRPM7 plays an essential role in fibrogenesis in human AF. Our study
opens a new avenue to explore the potential roles of Ca2+ signaling in fibrogenesis, which
will lead to better understanding of the mechanism of cardiac fibrogenesis, and could
ultimately results in development of more effective approaches for treatment of AF.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
NOVELTY AND SIGNIFICANCE
What is known?
• Atrial fibrosis is a hallmark feature of structural remodeling in atrial fibrillation
(AF).
• Previous studies have suggested that Ca2+ entry is essential for fibroblast function.
However, the Ca2+ signaling mechanisms in cardiac fibrogenesis have not
elucidated.
What new information does this article contribute?
• Here we report that the Ca2+-permeable cation channel TRPM7 is the major Ca2+-
permeable channel in human atrial fibroblasts.
• TRPM7-mediated Ca2+ entry is essential for TGF-β1-induced fibroblast
differentiation.
• TRPM7 is significantly up-regulated in AF fibroblasts and plays a key role in
enhanced fibroblast proliferation, differentiation, and collagen production during
AF.
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Summary
Atrial fibrosis is a major factor contributing to AF. Understanding the mechanism of
fibrogenesis is crucial for developing new therapeutic strategies for attenuating or reversing
fibrosis-associated AF. The aim of this study was to elucidate the Ca2+ signaling
mechanisms in fibroblasts and how Ca2+ signals contribute to fibrogenesis in AF. We
discovered that TRPM7, a Ca2+-permeable cation channel that possesses protein kinase
function, is the key Ca2+-permeable channel in human atrial fibroblasts. TRPM7 and
TRPM7-mediated Ca2+ signals were drastically up-regulated in AF patients, which
correlated with enhanced fibrogenesis in cells from these patients. This study identifies for
the first time the molecular nature of the major Ca2+-permeable channel in cardiac
fibroblasts, which helps to elucidate how Ca2+ signals contribute to fibrogenesis in human
AF. Also, our observation that TRPM7-mediated Ca2+ entry contributes to human AF
represents the first report of an important role of TRPM7 in human diseases. Our study
opens a new avenue to explore the potential role of Ca2+ signals in fibrogenesis, which
should lead to better understanding of the mechanisms of cardiac fibrogenesis and could
ultimately result in the development of more effective approaches for the treatment of AF.
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Non-standard Abbreviations and Acronyms
AF Atrial Fibrillation
NSR Normal sinus rhythm
TRPM7 Transient receptor potential melastatin related 7
TRP Transient receptor potential
TRPV2 Transient receptor potential V2
TRPV4 Transient receptor potential V4
TRPC6 Transient receptor potential C6
CABG Coronary Artery Bypass Graft
AngII Angiotensin II
2-APB 2-Aminoethoxydiphenyl borate
TGF-β1 Transforming growth factor β1
ECM Extracellular matrix proteins
shRNA Small hairpin RNA
4α-PDD 4α-Phorbol-12,13-didecanoate
DAG Diaglycerol
OAG 1-Oleoyl-2-acetyl-sn-glycerol
α-SMA alpha-Smooth Muscle Actin
EDG7 a Lysophospholipid/Lysosphingolipid Receptor
ROS Reactive oxygen species
Tg Thapsigargin
CCH Carbachol
LPA Oleoyl-lysophosphatidic acid
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Figure 1.
The endogenous TRPM7-like channels in human atrial fibroblasts resemble the
characteristics of recombinant TRPM7. A, Representative TRPM7-like currents elicited by a
voltage ramp protocol ranging from -120 to +100 mV. B, Single channel conductance of
TRPM7-like channel was 38.4 ± 1.6 pS (n=6). Representative recordings from inside-out
patches are shown in the inset. C, TRPM7-like inward current was potentiated by external
acidic pH solution. D, Concentration-dependent effects of external protons on TRPM7-like
currents. E, Biphasic effects of 2-APB on TRPM7-like currents, with inhibition and
potentiation at low and high 2-APB concentrations, respectively. F, Concentration-
dependent inhibition of 2-APB on TRPM7-like currents. Best fit with Hill equation yielded
IC50=32.1 ± 0.1 μM, nH=1.1 (mean ± SEM, n=5).
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Figure 2.
TRPM7 underlies the molecular basis of the TRPM7-like channel and that TRPM7-like
channel mediated Ca2+ entry constitutes the major Ca2+ influx in human atrial fibroblasts.
A, Typical recordings of TRPM7 over-expressed in HEK-293 cells after treatment with
scramble (Scr)-shRNA and TRPM7-shRNA. B, Average current amplitude of TRPM7.
TRPM7-shRNA decreased TRPM7 by about 70%. C, Current amplitude of TRPM7-like
current recorded in human atrial fibroblasts in a TRPM7-specific shRNA treated cell (Blue)
in comparison with that of a Scr-shRNA treated cell (Red). D, Mean current density of
TRPM7-like current in TRPM7-shRNA and Scra-shRNA treated cells. E, Ca2+ influx
mediated by TRPM7-like channel. Ca2+ influx was elicited by 20 mM Ca2+. The amplitude
of Ca2+ influx was normalized to the peak Ca2+ influx induced by 1 μM Ionomycin (Iono).
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TRPM7-shRNA significantly reduced the Ca2+ influx (Blue) in comparison with the Ca2+
influx obtained in scramble shRNA treated cells (Red). F, TRPM7 shRNA reduced Ca2+
influx in human atrial fibroblasts by 62% measured by normalized peak amplitude.
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Figure 3.
TRPV2, TRPV4 and TRPC6 currents were not detectable in atrial fibroblasts. A, TRPV2-
like current was not elicited by 2-APB (200 μM) in human atrial fibroblasts. B, Typical
recording of TRPV2 over-expressed in HEK293 cells. C, Time-dependent changes of
inward and outward currents of TRPV2 in HEK293 cells. D, 4α-PDD (1 μM) failed to
induce TRPV4-like current in human atrial fibroblasts. E, Representative recording of
recombinant TRPV4 activated by 1 μM 4α-PDD in HEK293 cells. F, Time-dependent
changes of inward and outward currents of TRPV4 in HEK293 cells. G, Activation of Gq-
linked EDG7 receptors in fibroblasts by Oleoyl-lysophosphatidic acid (LPA) could not
activate TRPC6-like current. H, Recombinant TRPC6 current activated by Carbachol (CCh)
in HM1 cells (HEK293 cells with over-expression of type 1 muscarinic receptor). I, Time-
dependent changes of inward and outward TRPC6 currents in HM1 cells. Please note that
the currents recorded in the beginning (in A, D, and G) were endogenous TRPM7 which
were inhibited by Mg2+ when the pipette solution dialyzed into the cell. Inward and outward
currents in C, F and I were measured at -100 and +100 mV respectively.
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Figure 4.
Up-regulation of endogenous TRPM7 in atrial fibroblasts from AF patients. A, Typical
TRPM7 recording in a freshly isolated fibroblast from AF patient. B, TRPM7 recorded in a
freshly isolated fibroblast from NSR patient. C, Average current density of TRPM7 from
each AF and NSR patient. Note that current amplitudes from all the AF patients are larger
than the biggest current amplitude in NSR patients. D, Average current density of
endogenous TRPM7 from all the fibroblasts in AF and NSR patients.
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Figure 5.
Increased Ca2+ influx in AF fibroblasts in comparison with that in NSR fibroblasts. A,
Changes of F340/F380 ratio under indicated conditions. There was more Ca2+ influx in the
fibroblasts from AF patients when the cells were perfused with 20 mM Ca2+. Ca2+ influx
was measured after the fibroblasts were cultured for 12 hrs which allows fibroblasts to
attach to the coverslips. B, Normalized F340/F380 ratio from a representative experiment
using the cells from AF and NSR patients. C, Average ratio of F340/F380 in fibroblasts
from AF and NSR patients. The ratio was normalized to the maximal response induced by 1
μM ionomycin.
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Figure 6.
Myofibroblast differentiation in cells from AF and NSR patients. A, Immunostaining with
antibody against α-SMA in fibroblasts from NSR and AF patients, respectively. Fibroblasts
from AF patients show a higher percentage of differentiated myofibroblasts in the absence
of TGF-β1treatment (P <0.01). TGF-β1(10 ng/ml) treatment induced 90% differentiated
myofibroblasts in cells from both AF and NSR patients. α-SMA is in red, and nuclei are
labeled in blue by TO-PROIII. B, Mean percentage of differentiated myofibroblasts in AF or
NSR patients with or without TGF-β1treatment. The basal differentiation (without TGF-
β1treatment) in AF patients is higher than that in NSR patients (P <0.01). C, TRPM7-
shRNA decreased Ca2+ inlux in atrial fibroblasts from AF patient . The average decrease of
Ca2+ influx by TRPM7-shRNA was 64%. D, The basal differentiation of atrial fibroblasts
from AF patient was significantly decreased by TRPM7-shRNA.
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Figure 7.
Effects of TRPM7 on fibroblast differentiation and proliferation. A, Differentiated
myofibroblasts detected by immunostaining of α-SMA (Red). Human atrial fibroblasts were
isolated from NSR patients and treated with Scr- or TRPM7-shRNA. Differentiation was
induced by 10 ng/ml TGF-β1. Differentiation percentage was obtained by counting the
number of differentiated cells (Red) divided by the total number of cells as identified by the
nuclei (Blue). B, Average percentage of differentiated myofibroblasts in Scr- or TRPM7-
shRNA treated cells. In TRPM7-shRNA treated cells, differentiation induced by TGF-β1was
not significantly different from that of cells without TGF-β1 induction (34.4 ± 7.2% and
23.5± 4.8% respectively; p >0.05). In Scr-shRNA treated cells, the differentiation induced
by TGF-β1 (61.0 ± 1.9%) was significantly higher than that in control cells (30.4 ± 6.1%).
C, Changes in α-SMA induced by 10 ng/ml TGF-β1 in TRPM7- or Scr-shRNA treated
mouse cardiac fibroblasts. TGFβ receptor blocker SB431542 (10 μM) was applied to the
control groups to minimize differentiation at basal level. α-SMA protein identified by α-
SMA antibody; GAPDH was used as loading control. Please note the significant decrease of
α-SMA in TRPM7-shRNA treated cells. Similar results were obtained in three separate
experiments. D, Effects of TRPM7-shRNA on human atrial fibroblast proliferation induced
by TGF-β1 (10 ng/ml).
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Figure 8.
Up-regulation of TRPM7 by TGF-β1. A, Representative recording of TRPM7 in control
human atrial fibroblasts and in fibroblasts treated with 10 ng/ml TGF-β1. B, Average current
amplitude of TRPM7 after TGF-β1 treatment in comparison with control cells. The current
density was 8.9 ± 1.2 (n=25) pA/pF in control and 15.6 ± 1.7 (n=26) pA/pF in TGF-β1
treated group. C, Up-regulation of TRPM7 by TGF-β1 evaluated in mouse cardiac
fibroblasts. Top: western blot results of TRPM7 in control and TGF-β1 treated groups;
Middle: expression of α-SMA in control and TGF-β1treated groups; Bottom: GAPDH used
as loading control. D, Average increase in TRPM7 and α-SMA expression induced by TGF-
β1. TRPM7 protein expression was increased by 3.8 ± 0.9 fold (n=4) and α-SMA was
increased by 2.1 ± 0.6 fold (n=4). E-F, Increased collagen production in human atrial
fibroblasts induced by TGF-β1 evaluated at mRNA (E) and protein (F) levels. Average data
were from three separate experiments.
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